{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:13:31Z","timestamp":1782162811224,"version":"3.54.5"},"reference-count":61,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/etm.2017.4313","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T04:33:44Z","timestamp":1491453224000},"page":"2828-2838","source":"Crossref","is-referenced-by-count":18,"title":["Effect of mesenchymal stem cells on Sj\u00f6gren-like mice and the microRNA expression profiles of splenic CD4+ T cells"],"prefix":"10.3892","volume":"13","author":[{"given":"Guang-Feng","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Shu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Xue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Dong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"key20180108135040_b1-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sj\u00f6gren's syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun Rev"},{"key":"key20180108135040_b2-etm-0-0-4313","first-page":"321","volume":"366","author":"Fox","year":"2005","journal-title":"Sj\u00f6gren's syndrome: Lancet"},{"key":"key20180108135040_b3-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of primary Sj\u00f6gren syndrome: A systematic review","volume":"304","author":"Ramos-Casals","year":"2010","journal-title":"JAMA"},{"key":"key20180108135040_b4-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: Fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"key20180108135040_b5-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2174\/138920112802273092","article-title":"Local activation and systemic dysregulation of T lymphocytes in Sj\u00f6gren's syndrome","volume":"13","author":"Busch","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"key20180108135040_b6-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/art.38264","article-title":"Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sj\u00f6gren's syndrome","volume":"66","author":"Altorok","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"key20180108135040_b7-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"854706","DOI":"10.1155\/2015\/854706","article-title":"Distribution of peripheral lymphocyte populations in primary sj\u00f6gren's syndrome patients","volume":"2015","author":"Sudzius","year":"2015","journal-title":"J Immunol Res"},{"key":"key20180108135040_b8-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0961203309348234","article-title":"The numbers of Foxp3+ Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome","volume":"19","author":"Sarigul","year":"2010","journal-title":"Lupus"},{"key":"key20180108135040_b9-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jdermsci.2010.06.011","article-title":"Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sj\u00f6gren's syndrome","volume":"59","author":"Yin","year":"2010","journal-title":"J Dermatol Sci"},{"key":"key20180108135040_b10-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbrc.2012.04.133","article-title":"Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sj\u00f6gren's syndrome","volume":"422","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108135040_b11-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/sji.12121","article-title":"Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sj\u00f6gren's syndrome","volume":"79","author":"Belkhir","year":"2014","journal-title":"Scand J Immunol"},{"key":"key20180108135040_b12-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.2006.064030","article-title":"Reversal of Sjogren's-like syndrome in non-obese diabetic mice","volume":"66","author":"Tran","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key20180108135040_b13-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/j.1834-7819.2010.01197.x","article-title":"Sj\u00f6gren's syndrome: A review of aetiology, pathogenesis, diagnosis and management","volume":"55","author":"Bayetto","year":"2010","journal-title":"Aust Dent J"},{"key":"key20180108135040_b14-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12016-007-8012-7","article-title":"Animal models of Sj\u00f6gren's syndrome","volume":"32","author":"Jonsson","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20180108135040_b15-etm-0-0-4313","first-page":"71","article-title":"Multi-lineage potential of human mesenchymal stem cells following clonal expansion","volume":"2","author":"Halleux","year":"2001","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"key20180108135040_b16-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4161\/org.6048","article-title":"The use of mesenchymal stem cells in tissue engineering: A global assessment","volume":"4","author":"Rosenbaum","year":"2008","journal-title":"Organogenesis"},{"key":"key20180108135040_b17-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"key20180108135040_b18-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"key20180108135040_b19-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"key20180108135040_b20-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"key20180108135040_b21-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"key20180108135040_b22-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"key20180108135040_b23-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.biocel.2010.08.008","article-title":"Bone marrow cells are a source of undifferentiated cells to prevent Sj\u00f6gren's syndrome and to preserve salivary glands function in the non-obese diabetic mice","volume":"42","author":"Khalili","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180108135040_b24-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"e38615","DOI":"10.1371\/journal.pone.0038615","article-title":"Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sj\u00f6gren's-like disease","volume":"7","author":"Khalili","year":"2012","journal-title":"PLoS One"},{"key":"key20180108135040_b25-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/keu316","article-title":"Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sj\u00f6gren's syndrome through the secretion of indoleamine 2,3-dioxygenase","volume":"54","author":"Liu","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key20180108135040_b26-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20180108135040_b27-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/eji.201040757","article-title":"Altered miR-146a expression in Sj\u00f6gren's syndrome and its functional role in innate immunity","volume":"41","author":"Pauley","year":"2011","journal-title":"Eur J Immunol"},{"key":"key20180108135040_b28-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jop.12187","article-title":"miR-146a and miR-155 expression in PBMCs from patients with Sj\u00f6gren's syndrome","volume":"43","author":"Shi","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"key20180108135040_b29-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cei.12664","article-title":"Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro\/SSA and La\/SSB in primary Sj\u00f6gren's Syndrome","volume":"182","author":"Gourzi","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"key20180108135040_b30-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fgene.2014.00071","article-title":"The contribution of epigenetics in Sj\u00f6gren's Syndrome","volume":"5","author":"Konsta","year":"2014","journal-title":"Front Genet"},{"key":"key20180108135040_b31-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108135040_b32-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","article-title":"The complexity of Sj\u00f6gren's syndrome: Novel aspects on pathogenesis","volume":"141","author":"Jonsson","year":"2011","journal-title":"Immunol Lett"},{"key":"key20180108135040_b33-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sj\u00f6gren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"key20180108135040_b34-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"394917","DOI":"10.1155\/2015\/394917","article-title":"Immunoregulation by mesenchymal stem cells: Biological aspects and clinical applications","volume":"2015","author":"Castro-Manrreza","year":"2015","journal-title":"J Immunol Res"},{"key":"key20180108135040_b35-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","article-title":"Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases","volume":"10","author":"Ben-Ami","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key20180108135040_b36-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.2009.115378","article-title":"Cytokines in Sjogren's syndrome: Potential therapeutic targets","volume":"69","author":"Roescher","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key20180108135040_b37-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/rheumatology\/keu417","article-title":"Biologic treatment in Sj\u00f6gren's syndrome","volume":"54","author":"Sada","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key20180108135040_b38-etm-0-0-4313","first-page":"1447","article-title":"Managing Sj\u00f6gren's Syndrome and non-Sj\u00f6gren Syndrome dry eye with anti-inflammatory therapy","volume":"8","author":"Coursey","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key20180108135040_b39-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2337\/db10-0542","article-title":"Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes","volume":"59","author":"Jurewicz","year":"2010","journal-title":"Diabetes"},{"key":"key20180108135040_b40-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"key20180108135040_b41-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2217\/imt.14.83","article-title":"Beyond regulatory T cells: The potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases","volume":"6","author":"Ballesteros-Tato","year":"2014","journal-title":"Immunotherapy"},{"key":"key20180108135040_b42-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12026-013-8452-5","article-title":"The IL-2\/IL-2R system: From basic science to therapeutic applications to enhance immune regulation","volume":"57","author":"Bayer","year":"2013","journal-title":"Immunol Res"},{"key":"key20180108135040_b43-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1582-4934.2008.00534.x","article-title":"Advances in microRNAs: Implications for immunity and inflammatory diseases","volume":"13","author":"Sonkoly","year":"2009","journal-title":"J Cell Mol Med"},{"key":"key20180108135040_b44-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J Autoimmun"},{"key":"key20180108135040_b45-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1371\/journal.pbio.0000045","article-title":"The genome sequence of Caenorhabditis briggsae: A platform for comparative genomics","volume":"1","author":"Stein","year":"2003","journal-title":"PLoS Biol"},{"key":"key20180108135040_b46-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"e12132","DOI":"10.1371\/journal.pone.0012132","article-title":"MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood","volume":"5","author":"Cox","year":"2010","journal-title":"PLoS One"},{"key":"key20180108135040_b47-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1038\/srep10397","article-title":"miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci Rep"},{"key":"key20180108135040_b48-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/imm.12227","article-title":"Role of miR-155 in the regulation of lymphocyte immune function and disease","volume":"142","author":"Seddiki","year":"2014","journal-title":"Immunology"},{"key":"key20180108135040_b49-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2014.10.003","article-title":"Immunodeficiency and immune dysregulation associated with proximal defects of T cell receptor signaling","volume":"31","author":"Notarangelo","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"key20180108135040_b50-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11481-012-9367-y","article-title":"\u03b2-catenin\/TCF-1 pathway in T cell development and differentiation","volume":"7","author":"Ma","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"key20180108135040_b51-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2011.06302.x","article-title":"Regulation of mature T cell responses by the Wnt signaling pathway","volume":"1247","author":"Xue","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key20180108135040_b52-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00296-006-0229-x","article-title":"Activation of MKK4 (SEK1), JNK and c-Jun in labial salivary infiltrating T cells in patients with Sj\u00f6gren's syndrome","volume":"27","author":"Soejima","year":"2007","journal-title":"Rheumatol Int"},{"key":"key20180108135040_b53-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12248","article-title":"Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases","volume":"176","author":"Patterson","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"key20180108135040_b54-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar1905","article-title":"The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells","volume":"8","author":"Dodeller","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"key20180108135040_b55-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbalip.2014.12.006","article-title":"PI3K signalling in inflammation","volume":"1851","author":"Hawkins","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20180108135040_b56-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.drudis.2014.04.002","article-title":"PI3K inhibitors as potential therapeutics for autoimmune disease","volume":"19","author":"Ball","year":"2014","journal-title":"Drug Discov Today"},{"key":"key20180108135040_b57-etm-0-0-4313","first-page":"125","article-title":"Transcriptional regulatory networks for CD4 T cell differentiation","volume":"381","author":"Christie","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20180108135040_b58-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/jidsymp.2013.29","article-title":"Janus kinases: An ideal target for the treatment of autoimmune diseases","volume":"16","author":"Gadina","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"key20180108135040_b59-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"mTOR signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"key20180108135040_b60-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cytogfr.2014.07.014","article-title":"TGF\u03b2 in T cell biology and tumor immunity: Angel or devil?","volume":"25","author":"Tu","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180108135040_b61-etm-0-0-4313","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1189\/jlb.0612293","article-title":"The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications","volume":"93","author":"Shachar","year":"2013","journal-title":"J Leukoc Biol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2017.4313\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T19:19:53Z","timestamp":1515439193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,6]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/etm.2017.4313"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4313","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}